The response to epidermal growth factor of human maxillary tumor cells in terms of tumor growth, invasion and expression of proteinase inhibitors
- 11 November 1991
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 49 (5) , 738-743
- https://doi.org/10.1002/ijc.2910490518
Abstract
Three cancer cell lines, IMC‐2, IMC‐3 and IMC‐4, were established from a single tumor of a patient with maxillary cancer. We examined responses to epidermal growth factor (EGF) of these 3 cell lines with regard to cell growth and tumor invasion. The growth rate of IMC‐2 in nude mice was markedly faster than that of the IMC‐3 and IMC‐4 cell lines. Assay for invasion through fibrin gels showed significantly enhanced invasive capacity of IMC‐2 cells in response to EGF, but no change for IMC‐3 and IMC‐4 cells. We examined response to EGF of IMC‐2 cells with regard to expression of a growth‐related oncogene (c‐fos), proteinases and their inhibiton. Expression of c‐fos was transiently increased in IMC‐2 cells at rates comparable to those seen in the 2 other lines in the presence of EGF. There was no apparent effect of EGF on the expression of urokinase‐type plasminogen activator and 72‐kDa type‐IV colla‐genase in IMC‐2 cells. In contrast, EGF specifically enhanced the expression of plasminogen activator inhibitor‐I (PAI‐1) and tissue inhibitor of metalloproteinases‐1 (TIMP‐1) in IMC‐2 cells. Our data suggest that proteinase inhibitors or other related factors may play an important role in tumor growth and invasion in response to EGF.Keywords
This publication has 22 references indexed in Scilit:
- Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitorExperimental Cell Research, 1991
- Counteraction of estradiol-induced activation of tissue-type plasminogen activator in a human breast cancer cell line by an anti-estrogen, LY117018International Journal of Cancer, 1991
- Enhanced production of tissue-type plasminogen activator by estradiol in a novel type variant of human breast cancer MCF-7 cell lineBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
- Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.The Journal of cell biology, 1989
- In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase.The Journal of cell biology, 1988
- Stimulation by EGF of the growth of EGF receptor‐hyperproducing tumor cells in athymic miceInternational Journal of Cancer, 1987
- Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate.The Journal of cell biology, 1986
- A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.The Journal of cell biology, 1985
- Induction of c-fos gene and protein by growth factors precedes activation of c-mycNature, 1984
- Levels of epidermal growth factor in mice tissues measured by a specific radioreceptor assayLife Sciences, 1976